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Supported bilayer lipid membraneNeuropathy target esterase (NTE) is an integral membrane protein localized in the endoplasmic reticulum in
neurons. Irreversible inhibition of NTE by certain organophosphorus compounds produces a paralysis known
as organophosphorus compound-induced delayed neuropathy. In vitro, NTE has phospholipase/lysopho-
spholipase activity that hydrolyses exogenously added single-chain lysophospholipids in preference to dual-
chain phospholipids, and NTE mutations have been associated with motor neuron disease. NTE's
physiological role is not well understood, although recent studies suggest that it may control the cytotoxic
accumulation of lysophospholipids in membranes. We used the NTE catalytic domain (NEST) to hydrolyze
palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (p-lysoPC) to palmitic acid in bilayer membranes
comprising 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and the ﬂuorophore 1-oleoyl-2-[12-[(7-
nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (NBD-PC). Translational
diffusion coefﬁcients (DL) in supported bilayer membranes were measured by ﬂuorescence recovery after
pattern photobleaching (FRAPP). The average DL for DOPC/p-lysoPC membranes without NEST was
2.44 µm2s-1±0.09; the DL for DOPC/p-lysoPC membranes containing NEST and diisopropylphosphoroﬂuor-
idate, an inhibitor, was nearly identical at 2.45±0.08. By contrast, the DL for membranes comprising NEST,
DOPC, and p-lysoPC was 2.28±0.07, signiﬁcantly different from the system with inhibited NEST, due to NEST
hydrolysis. Likewise, a system without NEST containing the amount of palmitic acid that would have been
produced by NEST hydrolysis of p-lysoPC was identical at 2.26±0.06. These results indicate that NTE's
catalytic activity can alter membrane ﬂuidity.+1 517 432 1105.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Neuropathy target esterase (NTE) is a 147-kDa serine esterase
located in endoplasmic reticulum membranes of neurons as well as
other cell types such as lymphocytes [1–5]. NTE activity has
traditionally been measured in vitro in the presence of its non-
physiological substrate phenyl valerate [6]. More recently, NTE
activity has been assessed with its more physiologically relevant
lysophospholipid substrates, which are distinguished from other
lipids by their single hydrophobic acyl chain [7–10]. Inhibition of NTE
activity by irreversible binding of certain organophosphorus (OP)
compounds to the active serine site results in a type of paralysis
known as OP compound-induced delayed neuropathy (OPIDN), for
which there is no effective treatment [11–13]. Only those OP
compounds that are involved in the aging reaction in which a
negative charge is created on the phosphyl group of NTE [14,15] have
been associated with OPIDN. Gene mutations in NTE have also beenlinked to motor neuron disease [16]. Although NTE plays essential
roles in embryonic development [17,18] and the protection of axons
from degeneration [19,20], its physiological function in mammalian
cells is not well understood.
Lysophospholipids form micelles and generally have a high
positive average intrinsic curvature because their projected head
group area is much larger than that of their tail group [21].
Lysophospholipids in healthy mammalian cell membranes constitute
between 0.5% and 6% of the total lipid weight. However, at elevated
concentrations, these lipids have been linked to a number of disease
states that include atherosclerosis, inﬂammation, and hyperlipidemia
[22,23]. It has been well established that lysophospholipids act as
neurotoxic agents when added to cell types such as cerebellar
granular neurons and rat spinal cord motor neurons at micromolar
concentrations in vitro [24,25]. Microscopy images have shown the
formation of bulges and bead-like structures in the aforementioned
cells as a result of an imbalance between exocytosis and endocytosis.
Lysophospholipids aid in the pore-forming exocytosis event that
releases neurotransmitters from presynaptic vesicles but inhibit the
subsequent endocytosis and vesicle ﬁssion events [25]. Channel-
independent inﬂux of calcium ions into cells from the extracellular
1534 A.J. Greiner et al. / Biochimica et Biophysica Acta 1798 (2010) 1533–1539environment, a supplementary effect of lysophospholipid addition,
has been shown to aid in presynaptic vesicle exocytosis [26]. A
possible mechanism of this inﬂux is the spontaneous formation of
pore structures in the lipid membrane [26].
It is known that lysophospholipases help control lysophospholipid
levels in biological membranes [22,27]. A recent study demonstrated
that the IC50 for lysophosphatidylcholine exposed to Neuro-2a cells
increased nearly three-fold upon the addition of recombinant NTE,
suggesting that a cellular role of NTE may involve controlling the
cytotoxic lysophospholipid concentration [9]. Other studies also
indicate that NTE enzymatic activity helps control lysophospholipid
concentrations [7,28].
Because of inherent difﬁculties in expressing the full-length NTE
[29], we used its catalytically active segment called NEST in this work.
NEST is a 55-kDa membrane-associated protein containing amino
acids 727–1216 of the full-length 1327-amino-acid NTE protein [8]. It
is used as a surrogate for NTE because it reacts in the same manner as
NTE with ester substrates and inhibitors [8,30]. In the present work,
we assessed the inﬂuence of NEST hydrolysis of lysophospholipids on
the ﬂuidity of bilayer lipid membranes, an important physical
property that affects trans-membrane diffusion [31], cell-to-cell
signaling [32], and membrane protein functionality [33]. Membrane
ﬂuidity was evaluated by measuring the translational diffusion
coefﬁcients (DL) and mobile fractions of ﬂuorescently tagged lipids
in several systems, using ﬂuorescence recovery after pattern photo-
bleaching (FRAPP).
2. Materials and methods
2.1. Chemicals and reagents
Phospholipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-
palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (p-lysoPC), and 1-
oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-
sn-glycero-3-phosphocholine (18:1–12:0 NBD-PC) were purchased
from Avanti Polar Lipids Inc. (Alabaster, AL) and used without further
puriﬁcation. CHAPS detergent (purity≥99% by high performance liquid
chromatography) was purchased from Anatrace (Maumee, OH).
Palmitic acid, imidazole, phenylmethylsulfonylﬂuoride (PMSF, puri-
ty≥98.5% by gas chromatography (GC)), and diisopropylphosphoro-
ﬂuoridate (DFP, 98% pure by GC) were purchased from Sigma Aldrich
(St. Louis, MO).
2.2. NEST expression and puriﬁcation
A gene that encodes human brain NEST was cloned into a pET-21b
vector containing a C-terminal His6-tag and an N-terminal T7
sequence. The expression vector was subsequently transformed into
E. coli BL21(DE3). A 50-mL culture of transformed E. coli was used to
inoculate a 5-L solution of terriﬁc broth (TB) media containing
ampicillin (0.1 mg/mL) in a fermentation vessel. Cells were grown for
12 h, with intermittent additions of glucose and ammonium phos-
phate, until the optical density of the culture reached ∼1.0. The
culture was then inducedwith isopropyl β-D-1-thiogalactopyranoside
(1 mM) and allowed to grow for an additional 4 h before harvesting.
Five grams of harvested cell pellet was then solubilized in 50-mL PEN
buffer (50 mM sodium phosphate, 300 mM NaCl, 0.5 mM EDTA, pH
7.4) containing 3% (w/v) CHAPS detergent. This solution was tip-
sonicated on ice ﬁve times at a power of approximately 80 W and
centrifuged at 14,900×g for 30 min at 4 °C. The supernatant was
incubated with 6 mL of nickel-nitrilotriacetic acid (Ni-NTA) resin
(Qiagen, Valencia, CA) for 1 h at 4 °C. Two minicolumns (3 mL per
column) were prepared by centrifugation of the protein-bound Ni-
NTA resin, and the minicolumns were washed six times with PEN
buffer containing 0.3% (w/v) CHAPS. NEST was collected in elution
fractions using PEN buffer containing 0.3% (w/v) CHAPS and 300 mMimidazole. SDS–PAGE was used to conﬁrm protein expression. Protein
concentration was estimated bymeasuring the absorbance at 280 nm.
NEST protein was then incorporated into liposomes to form
proteoliposomes as described below.
2.3. NEST proteoliposome formation
The 2-mM solutions of DOPC/NBD-PC (98:2, mol/mol) and DOPC/
p-lysoPC/NBD-PC (69:29:2 mol/mol/mol), which will be referred to
as 98:2 and 69:29:2, respectively, throughout the remainder of the
text, were prepared by evaporating chloroform solvent from the lipid
mixture with nitrogen gas, lyophilizing the lipid ﬁlm under vacuum
for 1 h, and hydrating the dry lipid ﬁlm with PEN buffer containing
10% (w/v) CHAPS. An upper limit p-lysoPC concentration of 29 mol%
was chosen because it is not possible to form bilayer structures at
lysophospholipid concentrations approaching 40 mol% [34]. The NEST
protein solution (0.1 mg/mL)was added to lipid/CHAPS solutions in a
880:1 lipid:protein (w/w) ratio to a ﬁnal volume of 5 mL. The CHAPS/
lipid/NEST solutions were then dialyzed against three 1-L exchanges
of PEN buffer for a total of 48 h at 4 °C using a snake skin dialysis
tubing with a 10,000 MWCO (Thermo Fisher Scientiﬁc, Rockford, IL).
Dialysis was performed at 4 °C to prevent NEST denaturation. After
48 h, DFP was added at 50 μM to stop the NEST-induced hydrolysis
reaction.
2.4. Inhibition studies
Stock solutions of 200 mM PMSF in 2-propanol and 10 mM DFP in
acetone were prepared and stored at 4 °C. PMSF at 1 mM and DFP at
50 μMwere preincubatedwith 0.1 mg/mL NEST in PEN buffer at room
temperature (23±2 °C) for 20 min before addition to lipid solutions
containing 10% (w/v) CHAPS. The two inhibitors, PMSF and DFP, are
similar in that they both irreversibly inhibit esterase activity.
However, they are also different in that the former does not undergo
the aging reaction, whereas the latter does. To ensure a high level of
enzyme inactivation, inhibitor concentrations used in our experi-
ments were relatively large compared to reported 20 min IC50 values
for PMSF (∼ 0.15 mM) and DFP (∼ 0.96 μM) against NEST activity at
37 °C [30]. Subsequent steps were repeated as listed above. NEST/
PMSF or NEST/DFP solutions (0.1 mg protein/mL) were added to
lipid/CHAPS solutions in a 880:1 lipid:protein (w/w) ratio to a ﬁnal
volume of 5 mL. The CHAPS/lipid/NEST solutions were then dialyzed
against three 1 L exchanges of PEN buffer for a total of 48 h at 4 °C.
2.5. Determination of free fatty acid concentration
A free fatty acid (FFA) assay kit from Roche Diagnostics (Penzberg,
Germany) was used to measure the concentration of fatty acids
incorporated into liposomes and proteoliposomes. The assay is based
on a reaction scheme developed by Shimizu [35]. Brieﬂy, FFA reacts
with coenzyme A (CoA) and adenosine 5′-triphosphate in the
presence of acyl-CoA synthetase to form acyl-CoA, adenosine 5′-
monophosphate, and pyrophosphate. Acyl-CoA then forms 2,3-enoyl
CoA and hydrogen peroxide in the presence of acyl-CoA oxidase. Upon
reactionwith 2,4,6-tribromo-3-hydroxy-benzoic acid and 4-aminoan-
tipyrine in the presence of peroxidase, hydrogen peroxide forms a red
dye, the absorbance of which is measured with a spectrophotometer.
To ensure that the assay was suitable for this study, chloroform-
solubilized palmitic acid was added to chloroform-solubilized lipids
and a lipid/palmitic acid ﬁlm was formed by drying with nitrogen gas
prior to lyophilization and hydration with PEN buffer containing 10%
(w/v) CHAPS. After liposome formation by dialysis, an additional 10%
(w/v) CHAPSwas added to the sample and the concentration of FFA in
the resulting mixed micelle structures (size measured with dynamic
light scattering) was veriﬁed using the kit. Due to the large expense of
doing this assay, experiments were only conducted in duplicates.
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Following dialysis, the concentration of FFA in liposomes and in
NEST proteoliposomes was measured after the addition of 10% (w/v)
CHAPS to 1-mL samples to form mixed micelle structures. A steady-
state condition was veriﬁed by measuring the FFA concentration 3 h
after the DFP addition. We noted that the partition coefﬁcient of
palmitic acid into 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) unilamellar liposomes at 23 °C is approximately 5.23×106
[36]. Although we provide no direct evidence that palmitic acid is
present within the membrane phase of unilamellar liposomes, the
large partition coefﬁcient for palmitic acid into DPPC suggests that
most of the palmitic acid molecules were associated with the lipid
bilayer rather than the aqueous phase.2.6. Dynamic light scattering (DLS)
Mean particle sizes and size distributions of liposomes and NEST
proteoliposomes in solution were measured with a Brookhaven
Instruments 90 Plus/BI-MAS/ZetaPlus machine (Holtsville, NY).2.7. Transmission electron microscopy (TEM)
A 10-μL aliquot of 69:29:2 liposomes, with and without NEST, was
diluted 100× with PEN buffer and ﬁxed on a copper-coated grid using
a 2% (w/v) uranyl acetate stain. Images were obtained with a JEOL
100CX TEM using an accelerating voltage of 100 kV.2.8. Deposition of supported lipid bilayers
Fused silica microscope slides (75×25×1 mm) were purchased
from Technical Glass Products, Inc. (Painesville, OH). The slides were
cleaned by bath sonication (Branson 1510, Branson Ultrasonic
Corporation, Danbury, CT) in detergent solution for 20 min, rinsed
with deionized water, baked at 160 °C for 4 h, and plasma treated
(Harrick Plasma, Ithaca, NY) with oxygen under vacuum (150 mTorr)
for 10 min immediately before bilayer deposition. Supported bilayer
lipid membranes (sBLMs) were deposited by liposome or proteolipo-
some fusion in a custom-made ﬂow cell described elsewhere [37]. The
ﬂow cellwas initiallywashedwith buffer, followed by a 1-h incubation
with liposome or NEST proteoliposome solution and a ﬁnal buffer
wash to remove unadsorbed particles. All experiments were
performed at room temperature (23±2 °C).2.9. Fluorescence recovery after pattern photobleaching
FRAPP was used to measure the translational diffusion coefﬁcients
(DL) and mobile fractions (m) of ﬂuorophores in sBLMs reconstituted
on silica microscope slides. The experimental setup has been
described in detail elsewhere [37]. Brieﬂy, a Ronchi ruling was placed
in the rear image plane of the microscope, creating a striped pattern
(periodicity of 25 μm in the sample plane) of alternating light and
dark fringes on the sample. Fluorophores in illuminated zones were
photobleached by exposure to the high-intensity laser beam.
Unbleached ﬂuorophores in the dark zones diffused into the
photobleached areas, leading to recovery of a spatially homogeneous
ﬂuorescence signal [38]. An aperture placed in the image plane in
front of the photomultiplier tube restricted the observation area,
resulting in an illuminated area of approximately 200 µm in diameter
and an observation area of 75 µm in diameter. This arrangement
prevented unbleached ﬂuorophores from diffusing from outside the
bleached (patterned) area into the observation zone during measure-
ments of ﬂuorescence recovery.The diffusion coefﬁcients and mobile fractions were extracted by
ﬁtting the following equation to the recovery data [38]:
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where f(t) is the post-bleach ﬂuorescence intensity (t≥0) normalized
with respect to the average pre-bleach ﬂuorescence intensity (tb0),
with t=0 being the time of the bleach pulse, DL the translational
diffusion coefﬁcient of ﬂuorophores within the patterned area, m the
mobile fraction, and a the stripe periodicity of the Ronchi ruling in the
sample plane [39]. Eq. (1) assumes a single diffusing species and a
single immobile species. For our experiments, the diffusing species
corresponded to ﬂuorophores in ﬂuid sBLMs and the immobile species
to ﬂuorophores that resided in unruptured vesicles attached to the
surface.
2.10. Statistical analysis
For each lipid system interrogated in this work, three separate
sBLM interfaces were formed on silica slides and each interface was
interrogated at ﬁve different locations along the bilayer. The diffusion
coefﬁcients (DL) and particle diameters reported are expressed as
means plus/minus standard deviations (x̄±Sx). Multiple comparison
ANOVA with a post hoc Tukey test (pb0.05) was used to determine if
the observed differences between the means are statistically
signiﬁcant.
3. Results and discussion
The structures of the phospholipids used in this work are shown in
Fig. 1. In particular, we note that the NBD ﬂuorescent moiety of the
NBD-PC is located in the tail region of the lipid. A reasonable
assumption is that after NEST hydrolysis of a p-lysoPC molecule, the
hydrophilic head group of the lipid will diffuse into the aqueous mass
outside the bilayer and the hydrophobic tail will remain trapped
inside the membrane. Thus, we expect that much of the dynamics of
NEST hydrolysis will be manifested in the hydrophobic region of the
membrane. Using NBD-PC for this work ensures that we have the
probe in the right location to interrogate its dynamics.
We interrogated three groups of reconstituted bilayer lipid
membranes (seven systems in all) carefully selected to provide
comparative data to aid the interpretation of the of the process
dynamics:
• Group A: BLMs consisting of 98 mol% DOPC and 2 mol% NBD-PC
reconstituted without NEST (system 1 in the analysis below), and
with NEST incorporated (2). System 1 is the basic BLM formulation
used in our lab and serves as an important control to assess the
effect of incorporating NEST into the membrane.
• Group B: BLMs consisting of 69 mol% DOPC, 29 mol% p-lysoPC and
2 mol% NBD-PC, with the following variations: no additional
constituents (3), with the NEST inhibitor DFP incorporated (4),
and with both DFP and NEST incorporated (5). These systems were
used to provide comparative data for situations where NEST
hydrolysis is essentially negligible.
• Group C: The ﬁrst system had a formulation of 69 mol% DOPC,
29 mol% p-lysoPC and 2 mol% NBD-PC, with NEST incorporated to
measure the effect of hydrolysis (6). The second system consisted of
69 mol% DOPC, 20 mol% p-lysoPC, 9 mol% palmitic acid, and 2 mol%
NBD-PC (7). The fraction of palmitic acid in this system is equivalent
to the amount of FFA that would be expected from NEST hydrolysis
in system 6, and was formulated to provide comparative data.
We used FRAPP to assess the diffusion and mobility of ﬂuor-
ophores imbedded in the hydrophobic region of each of the seven
Fig. 3. DLS results showing the transition of CHAPS/69:29:2/NEST micelles to
proteoliposomes during dialysis. The data represent means plus or minus standard
deviations (x̄±Sx) of three replicate dialysis runs. A Boltzmann sigmoidal function,
d=d2+((d1−d2)/(1+exp((t− t0)/τ))), was ﬁtted to the data. In this function, d is
the time-dependent mean particle diameter, t is time, d1 is the initial particle diameter,
d2 is the ﬁnal particle diameter, t0 is the center time value, and τ is the time constant.
The ﬁt had a correlation coefﬁcient of 0.999. Fitted parameters were as follows: d1=1.7±
0.6 nm, d2=43.0±0.5 nm, t0=12.9±0.4 h, and τ=2.7±0.2 h.
Fig. 1.Molecular structures of the lipids used in this study: (a) 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC), (b) 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
(p-lysoPC), and (c) the ﬂuorophore 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (NBD-PC). Note that the NBD
ﬂuorescent moiety of the NBD-PC lipid is located in the tail region of the lipid, enabling
probing of the hydrophobic region of the sBLM.
Fig. 2. (a) TEM image showing representative 69:29:2 liposomes after dialysis. (b) TEM
image showing a representative 69:29:2/NEST proteoliposome after dialysis. These
unilamellar liposomes and proteoliposomes were used to form sBLMs on fused silica.
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from liposomes or proteoliposomes formed by dialysis of solutions
with the appropriate constituents as described above.
3.1. Transmission electron microscopy
TEM images (Fig. 2) showed that 69:29:2 liposomes and 69:29:2/
NEST proteoliposomes formed after dialysis were unilamellar,
ensuring that sBLMs reconstituted from them would also be
unilamellar [21,40]. Because liposomes and NEST proteoliposomes
were subjected to high-vacuum conditions and to a high-energy
electron beam, it is difﬁcult to use TEM images to obtain the size
distribution of liposomes and proteoliposomes. Thus, those data were
obtained by dynamic light scattering (DLS).
3.2. Dynamic light scattering
We used DLS to assess the transition from mixed CHAPS/69:29:2
micelles to liposomes and mixed CHAPS/69:29:2/NEST micelles to
proteoliposomes by dialysis. This was done by measuring the mean
particle diameter as a function of time (Fig. 3). The DLS results show
that the mean diameter of NEST-containing micelles before dialysis
was 2.3±0.2 nm and that the steady-state mean diameter of
proteoliposomes after 30 h of dialysis was 40.8±3.1 nm. The
sigmoidal shape of the resulting data has been reported previously
for transition from micelles to liposomes via detergent dialysis
[41,42].The mean diameter of the 69:29:2 liposomes, without NEST, after
dialysis was not signiﬁcantly different from that of proteoliposomes
containing NEST, suggesting that, at the signiﬁcantly large lipid to
protein ratio (880:1 w/w) used in this study, the incorporation of
NEST has no effect on particle size.
Fig. 4. Conversion of p-lysoPC to palmitic acid as a function of time during dialysis. 100%
conversion of p-lysoPC to palmitic acid was assigned to 69:29:2 liposomes containing
uninhibited NEST after 48-h dialysis. The data represent the total number of moles of
FFA (palmitate) present at each time, expressed as a percentage of the total number of
moles of palmitoyl-lysoPC originally present in the liposome preparation. The data are
the means plus or minus standard deviations (x ̄±Sx) of two replicate assays for each
time period. The linear regression ﬁt had a correlation coefﬁcient of 0.990.
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Negligible conversions of DOPC or NBD-PC to FFA were measured
in 98:2 liposomes and in 98:2 proteoliposomes with NEST, in
agreement with previously published results showing that dual acyl
chain lipids are not readily hydrolyzed by NEST [8,9]. There were also
negligible conversions of DOPC, p-lysoPC, or NBD-PC to FFA in 69:29:2
liposomes, with and without the inhibitors PMSF and DFP, indicating
that p-lysoPC did not auto-hydrolyze and that the inhibitors used in
this study did not interact with lipids to form FFAs. Signiﬁcant
conversion of the DOPC, p-lysoPC, and NBD-PC mixture to FFA was
measured in 69:29:2 liposomes containing NEST after 48 h of dialysis
(Table 1 and Fig. 4). Control experiments showed negligible
conversion of DOPC and NBD-PC to FFA in 98:2 proteoliposomes
with NEST, as well as negligible conversion of DOPC, p-lysoPC, and
NBD-PC in the absence of NEST. Thus, the signiﬁcant levels of FFA
observed in the 69:29:2 liposomes were attributed to the conversion
of p-lysoPC to palmitic acid. FFA conversion values for p-lysoPC-
containing NEST proteoliposomeswere calculated as ratios of the total
moles of palmitic acidmeasured to the total moles of p-lysoPC present
before the addition of NEST. To aid in comparing data from different
systems, the mean conversion of p-lysoPC to palmitic acid in the
69:29:2 liposomes containing uninhibited NEST after 48 h of dialysis
was assigned a value of 100%. When NEST was mixed with PMSF and
DFP in separate experiments prior to dialysis, the mean conversions of
p-lysoPC decreased from 100% to 17% and 0.3%, respectively. Thus, the
inhibition of NEST activity by DFP and PMSF reduced the conversion of
p-lysoPC to palmitic acid by ∼83 and ∼100%, respectively (Table 1),
demonstrating signiﬁcant depression of NEST activity in these
systems. The speciﬁc activities are shown in Table 1 in terms of FFA
produced per mg NEST per hour after a reaction time of 48 h. We
should note that, at the concentrations of CHAPS used in our
experiments, we did not observe signiﬁcant inhibition of NEST
activity due to the presence of CHAPS in the mixed micelles (Figs. 2
and 4).
3.4. Translational diffusion in supported bilayer lipid membranes
Diffusion coefﬁcients (DL) and mobile fractions (m) of NBD
ﬂuorophores in sBLMs reconstituted on fused silica slides were
measuredwith FRAPP. There was no statistical difference between the
mean DL values for the samples in group A (98:2 with and withoutTable 1
Percent conversion and speciﬁc activity of p-lysoPC to palmitic acid for several
systemsa.
Systemb Percent
conversionc
Percent
inhibitiond
Speciﬁc activity e
(μmol FFA produced/mg/h)
69:29:2fA 0.3±0.1 — —
69:29:2 (with PMSF)A 0.4±0.1 — —
69:29:2 (with DFP)A 0.3±0.1 — —
69:29:2 (with NEST)B 100±7 — (3.6±0.24)×10−2
69:29:2 (with NEST and
PMSF)C
17±1 83±7 (6.3±0.24)×10−3
69:29:2 (with NEST and
DFP)A
0.3±0.1 99.7±7.0 (1.2±0.24)×10−4
a Data represent means plus or minus standard deviations (x ̄±Sx) of two duplicate
assays.
b Systems that are not statistically different are labeled by common capital letters
(ANOVA, Tukey post hoc test, pb0.05).
c 100% conversion of p-lysoPC to palmitic acid was assigned to the mean conversion
value in 69:29:2 liposomes containing uninhibited NEST after 48-h dialysis.
d Percent reduction in conversion for systems with NEST and either DFP or PMSF,
relative to the mean conversion value in 69:29:2 liposomes containing uninhibited
NEST after 48-h dialysis.
e Speciﬁc activities are reported in terms of FFA produced per mg NEST and after a
time period of 48 h.
f 69:29:2 is 69 mol% DOPC, 29 mol% p-lysoPC, and 2 mol% NBD-PC.NEST), as shown in Fig. 5. Hence, incorporating NEST into the sBLM at
a sufﬁciently large lipid to membrane protein ratio (880:1 w/w) does
not affect the translational diffusion of lipids. In a previous study,
proteoliposomes with relatively small lipid to membrane protein
ratios had similar diffusion characteristics as pure liposomes without
protein, suggesting that protein concentration has little effect on the
dynamics of the system [43]. There were no statistical differences
between the average mobile fractions of the seven systems studied
(Fig. 6). This suggests that the degree of liposome rupture and bilayer
formation was essentially identical in all the reconstituted sBLMs. In
particular, the fact that themobile fractions of NBD in 98:2 sBLMswith
and without NEST were not statistically different provides an
indication that the protein did not impede proteoliposome ruptureFig. 5.Diffusion coefﬁcients (DL) of NBD-PC in sBLMs for several systems (please see key
below). The data are means plus or minus standard deviations (x ̄±Sx) from three
different bilayers. Systems with DL values that are not statistically different are labeled
by a common letter (ANOVA, Tukey post hoc test, pb0.05). DL for 69:29:2 bilayers
treated with PMSF and 69:29:2 bilayers with PMSF-inhibited NEST (data not shown)
were not statistically different from those of 69:29:2 lipid systems with DFP in place of
PMSF. [⁎Key: System 1: 98 mol% DOPC, 2 mol% NBD-PC; 2: same as in system 1 but with
NEST; 3: 69 mol% DOPC, 29 mol% p-lysoPC, and 2 mol% NBD-PC; 4: same as in system 3
but with DFP; 5: same as in system 3 but with NEST and DFP; 6: same as in system 3 but
with NEST only; 7: 69 mol% DOPC, 20 mol% p-lysoPC, 9 mol% palmitic acid, and 2 mol%
NBD-PC].
Fig. 6. Mobile fractions of NBD-PC for several systems (see key below). The data are
means plus or minus standard deviations (x̄±Sx) from three different bilayers. No
statistical difference was observed between the seven systems (ANOVA, Tukey post hoc
test, pb0.05), indicating that neither lipid composition nor the presence of protein and/
or inhibitors inﬂuenced the rupture of liposomes to form bilayers. [⁎Key: System 1:
98 mol% DOPC, 2 mol% NBD-PC; 2: same as in system 1 but with NEST; 3: 69 mol%
DOPC, 29 mol% p-lysoPC, and 2 mol% NBD-PC; 4: same as in system 3 but with DFP; 5:
same as in system 3 but with NEST and DFP; 6: same as in system 3 but with NEST only;
7: 69 mol% DOPC, 20 mol% p-lysoPC, 9 mol% palmitic acid, and 2 mol% NBD-PC].
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used. On the other hand, no ﬂuorescence recovery was measured
when proteoliposomeswith lipid to protein ratios less than 80:1 (w/w)
were adsorbed on silica slides, indicating negligible mobile fractions
(data not shown). This result is consistent with proteoliposome
adsorption without subsequent sBLM formation.
The average translational diffusion coefﬁcient for 69:29:2 sBLMs
was higher than for 98:2 sBLMs. This should be expected based on
simple geometric considerations. P-lysoPC has a headgroup area that
is essentially the same as the dual acyl chain lipids. Therefore, when
the lipid is incorporated into a supported BLM, it provides essentially
equivalent packing levels in the headgroup region of the bilayer.
However, its single acyl chain leads to lower packing densities in the
hydrophobic regions of the bilayer, thus making the system more
ﬂuid. The increase in membrane ﬂuidity upon addition of p-lysoPC to
model membranes has been observed previously, although our data
show amore modest increase in the DL than was reported by Leu et al.
[44], who attributed the increase in ﬂuidity upon addition of p-lysoPC
to DOPC bilayers to a decrease in tail group van derWaals interactions
between adjacent lipids [44]. The other two systems in group B
(69:29:2 sBLMs containing DFP (system 4) and 69:29:2 sBLMs
containing both NEST and its inhibitor DFP (system 5) in which no
hydrolysis occurred) yielded DL values that were not statistically
different from those of the pure 69:29:2 sBLMs. Thus, the incorpo-
ration of DFP alone or NEST and DFP together into a reconstituted
bilayer did not signiﬁcantly inﬂuence the ﬂuidity of the membrane.
This is consistent with the results observed in Group A, where no
statistical difference was detected between the ﬂuidities of 98:2 DOPC
bilayer with and without NEST.
3.5. NEST-induced hydrolysis of p-lysoPC to palmitic acid decreases
membrane ﬂuidity
Incorporation of NEST into a 69:29:2 sBLMs led to a statistically
lower average DL value, indicating a less ﬂuid membrane. This result
is clearly due to conversion of p-lysoPC to palmitic acid by NEST
hydrolysis and can also be explained on geometric considerations. As
discussed earlier, the headgroup of the p-Lyso PC lipid will likely
migrate into the aqueous phase upon hydrolysis, while the hydro-
carbon tail remains in the hydrophobic region of the membrane. Thenet result is that the headgroup area will contract somewhat (loss of
headgroup space upon p-Lyso PC hydrolysis), leading to a denser
hydrophobic region in which the diffusion of constituent species is
retarded. We have demonstrated that hydrolysis of p-lysoPC by NEST
decreases DL in model bilayer membranes (system 6) and that
inhibition of NEST activity by DFP (system 5) or PMSF negates this
effect. Since palmitic acid is formed by NEST-induced hydrolysis of p-
lysoPC, we can determine if the decrease in membrane ﬂuidity is
solely the result of uninhibited NEST. To assess this, we adjusted the
lipid composition a priori to correspond to the 100% p-lysoPC conver-
sion to palmitic acid we measured with the FFA assay. The resulting
system contained 69 mol% DOPC, 20 mol% p-lysoPC, 9 mol% palmitic
acid, and 2 mol% NBD-PC as the ﬂuorophore. ThemeanDLmeasured in
sBLMs with this composition was not statistically different from that
measured in 69:29:2 sBLMs containing uninhibited NEST, demon-
strating that the reduction in ﬂuidity is solely the result of NEST
hydrolysis.
The ability of saturated fatty acids such as palmitic acid to decrease
BLM ﬂuidity has been well documented [45–49]. For example, addition
of palmitic acid to DOPC bilayers has been shown by digital scanning
calorimetry to increase the gel-to-liquid-crystalline phase transition
temperature, which is an indication of a less ﬂuid bilayer [50]. A two-
dimensional Voronoi tessellation analysis of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE) bilayers showed that, upon addition of
palmitic acid, the area per constituent lipid decreasedwhile the area per
palmitic acid molecule remained constant [50]. This suggests that
palmitic acid is incompressible within the bilayer and acts to decrease
the void space between lipids, leading to a decrease in the area per lipid
and a decrease in membrane ﬂuidity [50]. Electron paramagnetic
resonance (EPR) measurements also demonstrated that membrane
ﬂuidity decreased in HepG2 cells exposed to palmitic acid [50]. A
molecular dynamics simulation of palmitic acid in 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC) bilayers also predicted that the
carboxyl carbon atomof the protonatedneutral formof the acid embeds
itself deeply into the membrane, adjacent to the ester group of the
DMPC lipids [51]. Palmitic acid molecules at this position in the bilayer
induce tighter lateral packing, stretching of hydrophobic lipid chains,
and increased lipid order [51]. Another study involving addition of
stearic acid to Langmuir monolayers comprising 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) and cholesterol showed an increase
in monolayer rigidity with increasing stearic acid concentration [52].
4. Conclusions
We have demonstrated that, at sufﬁciently large lipid to protein
ratios, NEST proteoliposomes adsorbed onto silica substrates rupture to
form ﬂuid sBLMs. We have used FRAPP to study seven different sBLMs
formulations to assess the effect of the hydrolysis of 1-palmitoyl-2-
hydroxy-sn-glycero-3-phosphocholine (p-lysoPC) by the catalytic
domain of NTE (NEST) on the ﬂuidity of the systems. We can draw
three important conclusions based on the results of this study. First,
NEST hydrolysis induces a statistically signiﬁcant decrease in theﬂuidity
of sBLMs reconstituted on silica. Second, it has been proposed that one
physiological role ofNTE is tomaintain lysophospholipid homeostasis in
mammalian cells. The results of this study suggest that BLMﬂuiditymay
provide a convenientphysicalmeasurement that could beused to assess
this function. Third, by extension of this work with NEST in model
membranes, we propose that the physiological enzymatic activity of
NTE may be manifested in maintaining bilayer membrane ﬂuidity in
intact cells.
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